The Safety and Efficacy of RIC on Adult Moyamoya Disease
NCT04012268
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Moyamoya Disease
Interventions
DEVICE:
RIC
DRUG:
Aspirin
Sponsor
Capital Medical University